SCHEMBL9109616

SCHEMBL9109616

CC(=O)Nc1cc(-c2cc(C(=O)NC(C)C)c(-c3ccccc3Cl)o2)c(C)cn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3C3 Q8NEB9 1/20 0.42
TSHR P16473 1/20 0.42
ALDH1A1 P00352 4/20 0.42
KMT2A Q03164 3/20 0.42
LMNA P02545 2/20 0.42
KDM4E B2RXH2 2/20 0.40
MEN1 O00255 2/20 0.40
LIMK1 P53667 1/20 0.39
MAPT P10636 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 3/20 0.37
TDP1 Q9NUW8 2/20 0.37
ROCK2 O75116 2/20 0.37
NPC1 O15118 2/20 0.36
TP53 P04637 1/20 0.36
JAK2 O60674 1/20 0.36
JAK1 P23458 1/20 0.36
TYK2 P29597 1/20 0.36
EIF2S1 P05198 1/20 0.35
EIF2AK3 Q9NZJ5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9108275 0.90 PIK3C3 (0.42) PIK3C3ALDH1A1KMT2ALMNAKDM4E
SCHEMBL9890033 0.88 PIK3C3 (0.44) PIK3C3ALDH1A1KMT2ALMNAKDM4E
SCHEMBL9888609 0.88 RAB9A (0.44) PIK3C3ALDH1A1KMT2ALMNAKDM4E
SCHEMBL9106554 0.88 HPGD (0.42) PIK3C3ALDH1A1KMT2ALMNAKDM4E
SCHEMBL9890501 0.88 KMT2A (0.39) PIK3C3ALDH1A1KMT2ALMNAKDM4E
SCHEMBL9106623 0.88 KMT2A (0.39) PIK3C3ALDH1A1KMT2ALMNAKDM4E
SCHEMBL9108874 0.88 PIK3C3 (0.46) PIK3C3ALDH1A1KMT2ALMNAKDM4E
SCHEMBL9108010 0.87 KMT2A (0.42) PIK3C3ALDH1A1KMT2ALMNAKDM4E
SCHEMBL9107473 0.87 PIK3C3 (0.43) PIK3C3ALDH1A1KMT2ALMNAKDM4E
SCHEMBL9108369 0.86 KMT2A (0.39) PIK3C3ALDH1A1KMT2ALMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8859768-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-10-14 US disclosed
US-8859768-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-10-14 US disclosed
US-20120142732-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-06-07 US disclosed
US-20120142732-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142732-A1 HETEROARYLS AND USES THEREOF PIK3R4, PIK3C2B, PIK3R1 PIK3C3 52/4885TSHR 4109/4885ALDH1A1 1905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.